Does Oral Folic Acid Lower Total Homocysteine Levels and Improve Endothelial Function in Children With Chronic Renal Failure?
- 16 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (15) , 1810-1815
Abstract
Background — Accelerated vascular disease is common in chronic renal failure (CRF) and accounts for significant mortality and morbidity. Elevated homocysteine levels may contribute by an effect on endothelial function. Methods and Results — We performed a double-blind placebo-controlled randomized crossover trial of folic acid at 5 mg/m 2 in 25 normotensive children 12±3 (7 to 17) years of age with CRF (glomerular filtration rate 26.8±13.2 mL/min per 1.73 m 2 ) of noninflammatory etiology. Each subject underwent two 8-week periods of folic acid and placebo separated by an 8-week washout period. The effect of folic acid on homocysteine levels, LDL oxidation, and both endothelial-dependent and -independent vascular function were measured. After oral folic acid, serum folate levels rose from 11.7±4.25 to 635±519 μg/L ( P =0.001), red cell folate levels rose from 364±195 to 2891±2623 μg/L ( P P =0.03). In addition, there was a significant improvement in flow-mediated dilatation (FMD) (endothelial-dependent dilatation) from 7.21±2.8% to 8.47±3.01% ( P =0.036) with no change in response to glyceryl trinitrate (endothelial-independent dilatation). There was no significant change in FMD or glyceryl trinitrate during the placebo phase. There was, however, no significant difference in final FMD after placebo or folic acid. Lag times for LDL oxidation were prolonged during the treatment phase (58.4±18.7 to 68.1±25.9 minutes, P =0.01). Conclusion — Folic acid supplementation in children with CRF may improve endothelial function with an increased resistance of LDL to oxidation.Keywords
This publication has 25 references indexed in Scilit:
- Oral folate enhances endothelial function in hyperhomocysteinaemic subjectsEuropean Journal of Clinical Investigation, 1999
- Hyperhomocyst(e)inaemia in children with chronic renal failureNephrology Dialysis Transplantation, 1999
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- The oxidant stress of hyperhomocyst(e)inemia.Journal of Clinical Investigation, 1996
- Total Plasma Homocysteine and Cardiovascular Risk ProfileJAMA, 1995
- Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.Heart, 1995
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Cardiovascular risks: New insights from FraminghamAmerican Heart Journal, 1988